Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, and is
strongly associated with the metabolic syndrome. In the last decade, it has become apparent …

Alcoholic liver disease (ALD) is a primary consequence of heavy and prolonged drinking.
ALD contributes to the bulk of liver disease burden worldwide. Progression of ALD is a …

The incidence of hepatocellular carcinoma (HCC) is increasing in industrialized societies;
this is likely secondary to the increasing burden of non-alcoholic fatty liver disease (NAFLD) …

Non‐alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed
countries, and accumulating evidence suggests it as the hepatic manifestation of the metabolic …

Epithelial-mesenchymal transitions (EMTs) play an important role in tissue construction during
embryogenesis, and evidence suggests that this process may also help to remodel some …

Liver inflammation is greater in nonalcoholic steatohepatitis (NASH) than steatosis, suggesting
that immune responses contribute to nonalcoholic fatty liver disease (NAFLD) progression…

Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis. Recently, we showed
that NASH‐related cirrhosis is associated with Hedgehog (Hh) pathway activation. The gene …

Objective Immune responses are important in dictating non-alcoholic steatohepatitis (NASH)
outcome. We previously reported that upregulation of hedgehog (Hh) and osteopontin (OPN…

BACKGROUND & AIMS: Repair responses define the ultimate outcomes of liver disease.
This study evaluated the hypothesis that fibrogenic repair in nonalcoholic fatty liver disease (…

Nonalcoholic fatty liver disease (NAFLD) is a potentially progressive liver disease that culminates
in cirrhosis. Cirrhosis occurs more often in individuals with nonalcoholic steatohepatitis …